Sorafenib for Recurrent Hepatocellular Carcinoma after Liver Transplantation.

Sorafenib for Recurrent Hepatocellular Carcinoma after Liver Transplantation. J Korean Med Sci. 2018 Nov 05;33(45):e286 Authors: Kim BH, Park JW PMID: 30402051 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/30402051?dopt=Abstract

Source: J Korean Med Sci - November 5, 2018 Category: General Medicine Authors: Kim BH, Park JW Tags: J Korean Med Sci Source Type: research